Rifampicin-resistant tuberculosis
MONDO:0100479A form of drug-resistant tuberculosis that is resisant to rifampicin with or without resistance to other antitubercular medications.
Also known as: RR-TB, rifampicin-resistant TB
25 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New hope for kids with Drug-Resistant TB: bedaquiline studied in children
Disease control CompletedThis study looked at how safe and tolerable the drug bedaquiline is for children and teens with rifampin-resistant tuberculosis, including those also living with HIV. Fifty-four participants received bedaquiline along with their regular TB treatment for 24 weeks. Researchers meas…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for kids with Drug-Resistant TB: pretomanid dose study completed
Disease control CompletedThis study tested a single dose of the drug pretomanid in 32 children with rifampicin-resistant tuberculosis (TB). The goal was to see how the drug moves through the body and whether it is safe when added to their regular TB treatment. The children were monitored for 48 hours aft…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Hotspot vs clinic: which TB hunt saves more lives?
Knowledge-focused CompletedThis study compares two strategies for finding undiagnosed tuberculosis (TB) in peri-urban Uganda. One strategy sets up screening at a large health clinic, while the other sends mobile screening teams into local hotspots where TB is thought to be most common. Researchers will tra…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC